EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Multidrug Resistant Pseudomonas aeruginosa in Clinical Settings: A Review of Resistance Mechanisms and Treatment Strategies

Beth Schwartz iD, Katherine Klamer, Justin Zimmerman, Pramodini B Kale-Pradhan iD, Ashish Bhargava iD

Pathogens · 07.11.2024 · 13 (11) · 975

DOI: 10.3390/pathogens13110975 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 07.11.2024. Verfasst von Beth Schwartz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Henry Ford St. John Hospital, Detroit, MI 48236, USA. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Pseudomonas Infections, Drug Resistance, Multiple, Bacterial, Anti-Bacterial Agents. Die Arbeit wurde bisher 77-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pseudomonas aeruginosa is causing increasing concern among clinicians due to its high mortality and resistance rates. This bacterium is responsible for various infections, especially in hospital settings, affecting some of the most vulnerable patients. Pseudomonas aeruginosa has developed resistance through multiple mechanisms, making treatment challenging. Diagnostic techniques are evolving, with rapid testing systems providing results within 4–6 h. New antimicrobial agents are continuously being developed, offering potential solutions to these complex clinical decisions. This article provides a review of the epidemiology, at-risk populations, resistance mechanisms, and diagnostic and treatment options for Pseudomonas aeruginosa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaPseudomonas InfectionsDrug Resistance, Multiple, BacterialAnti-Bacterial AgentsHumansMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Pseudomonas aeruginosadrug resistantinfectious diseasesmultidrug resistance

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Henry Ford St. John Hospital, Detroit, MI 48236, USA.
  • Thomas Mackey Center for Infectious Disease, Henry Ford St. John Hospital, Detroit, MI 48201, USA.
  • Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Science, Wayne State University, Henry Ford St. John Hospital, Detroit, MI 48201, USA.
  • School of Medicine, Wayne State University, Detroit, MI 48021, USA.

ORCID-Profile: Beth Schwartz, Pramodini B Kale-Pradhan, Ashish Bhargava

Zitieren

APA

Schwartz, B., Klamer, K., Zimmerman, J., Kale-Pradhan, P. B., & Bhargava, A. (2024). Multidrug Resistant Pseudomonas aeruginosa in Clinical Settings: A Review of Resistance Mechanisms and Treatment Strategies. Pathogens, 13(11), 975. https://doi.org/10.3390/pathogens13110975

Vancouver

Schwartz B, Klamer K, Zimmerman J, Kale-Pradhan PB, Bhargava A. Multidrug Resistant Pseudomonas aeruginosa in Clinical Settings: A Review of Resistance Mechanisms and Treatment Strategies. Pathogens. 2024;13(11):975. doi:10.3390/pathogens13110975

BibTeX
@article{Schwartz2024,
  author = {Schwartz, Beth and Klamer, Katherine and Zimmerman, Justin and Kale-Pradhan, Pramodini B and Bhargava, Ashish},
  title = {Multidrug Resistant Pseudomonas aeruginosa in Clinical Settings: A Review of Resistance Mechanisms and Treatment Strategies},
  journal = {Pathogens},
  year = {2024},
  volume = {13},
  number = {11},
  pages = {975},
  doi = {10.3390/pathogens13110975}
}
Kostenlos starten →